DE2622394A1 - Implantationskatheter - Google Patents
ImplantationskatheterInfo
- Publication number
- DE2622394A1 DE2622394A1 DE19762622394 DE2622394A DE2622394A1 DE 2622394 A1 DE2622394 A1 DE 2622394A1 DE 19762622394 DE19762622394 DE 19762622394 DE 2622394 A DE2622394 A DE 2622394A DE 2622394 A1 DE2622394 A1 DE 2622394A1
- Authority
- DE
- Germany
- Prior art keywords
- catheter
- ethylene
- acrylic acid
- catheter according
- catheters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000002513 implantation Methods 0.000 title claims description 10
- 239000000463 material Substances 0.000 claims description 17
- 229920001577 copolymer Polymers 0.000 claims description 16
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 11
- 239000005977 Ethylene Substances 0.000 claims description 11
- 210000004204 blood vessel Anatomy 0.000 claims description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 9
- -1 hydrogen ions Chemical class 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 229940039231 contrast media Drugs 0.000 claims description 3
- 239000002872 contrast media Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 3
- 210000003462 vein Anatomy 0.000 claims description 3
- 210000001367 artery Anatomy 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 238000012806 monitoring device Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 230000002785 anti-thrombosis Effects 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 description 24
- 208000001297 phlebitis Diseases 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 206010057267 Periphlebitis Diseases 0.000 description 10
- 201000005060 thrombophlebitis Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 229920000557 Nafion® Polymers 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 229920006226 ethylene-acrylic acid Polymers 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 241001631457 Cannula Species 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000003328 fibroblastic effect Effects 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000001361 intraarterial administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000002885 thrombogenetic effect Effects 0.000 description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/064—Use of macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57878375A | 1975-05-19 | 1975-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2622394A1 true DE2622394A1 (de) | 1976-12-02 |
Family
ID=24314301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19762622394 Ceased DE2622394A1 (de) | 1975-05-19 | 1976-05-19 | Implantationskatheter |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS521987A (enrdf_load_stackoverflow) |
| CA (1) | CA1054893A (enrdf_load_stackoverflow) |
| DE (1) | DE2622394A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2311559A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1504101A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0010621A1 (de) * | 1978-10-06 | 1980-05-14 | Intermedicat GmbH | Verfahren zur Herstellung eines Kunststoffverweilkatheters mit negativ geladener Oberfläche und danach hergestellter Verweilkatheter |
| EP3613446A1 (de) * | 2018-08-23 | 2020-02-26 | UroNova GmbH medizinische Implantate | Implantierbares medizinprodukt mit dauerhaft negativ geladener oberfläche |
| CN115003233A (zh) * | 2019-12-20 | 2022-09-02 | 皇家飞利浦有限公司 | 慢性凝块的电解重塑 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5841862B2 (ja) * | 1977-01-08 | 1983-09-14 | テルモ株式会社 | 医療用器具 |
| US4377010A (en) | 1978-11-08 | 1983-03-22 | The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland | Biocompatible material comprising a base polymer bulk graft polymerized with an ethylenically unsaturated carboxylic acid |
| EP0011795A1 (de) * | 1978-11-22 | 1980-06-11 | Intermedicat GmbH | Verfahren zur Herstellung von als Wunddrainagesonden dienenden Kunststoffschläuchen, insbesondere solcher mit antithrombogener Oberfläche, und hergestellte Kunststoffschläuche |
| EP0484057A3 (en) * | 1990-11-02 | 1993-04-21 | The Dow Chemical Company | Antithrombogenic surfaces, their preparation, and materials therefore |
| GB2575487B (en) * | 2018-07-12 | 2023-02-08 | Cook Medical Technologies Llc | Coated medical device and method of coating such a device |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609768A (en) * | 1969-06-16 | 1971-10-05 | Becton Dickinson Co | Anticoagulant material having charged electrostatic surfaces suitable for use in prosthetic devices |
| US3633578A (en) * | 1970-06-24 | 1972-01-11 | American Cyanamid Co | Method of maintaining the integrity of blood |
| US3663288A (en) * | 1969-09-04 | 1972-05-16 | American Cyanamid Co | Physiologically acceptible elastomeric article |
| DE2357354A1 (de) * | 1973-04-13 | 1974-10-24 | Meadox Medicals Inc | Katheter, welcher keine thromben erzeugt |
-
1976
- 1976-05-14 GB GB2001676A patent/GB1504101A/en not_active Expired
- 1976-05-18 FR FR7614962A patent/FR2311559A1/fr active Granted
- 1976-05-18 CA CA252,816A patent/CA1054893A/en not_active Expired
- 1976-05-19 DE DE19762622394 patent/DE2622394A1/de not_active Ceased
- 1976-05-19 JP JP51056768A patent/JPS521987A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609768A (en) * | 1969-06-16 | 1971-10-05 | Becton Dickinson Co | Anticoagulant material having charged electrostatic surfaces suitable for use in prosthetic devices |
| US3663288A (en) * | 1969-09-04 | 1972-05-16 | American Cyanamid Co | Physiologically acceptible elastomeric article |
| US3633578A (en) * | 1970-06-24 | 1972-01-11 | American Cyanamid Co | Method of maintaining the integrity of blood |
| DE2357354A1 (de) * | 1973-04-13 | 1974-10-24 | Meadox Medicals Inc | Katheter, welcher keine thromben erzeugt |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0010621A1 (de) * | 1978-10-06 | 1980-05-14 | Intermedicat GmbH | Verfahren zur Herstellung eines Kunststoffverweilkatheters mit negativ geladener Oberfläche und danach hergestellter Verweilkatheter |
| EP3613446A1 (de) * | 2018-08-23 | 2020-02-26 | UroNova GmbH medizinische Implantate | Implantierbares medizinprodukt mit dauerhaft negativ geladener oberfläche |
| US11439729B2 (en) | 2018-08-23 | 2022-09-13 | UroNova GmbH medizinische Implantate | Implantable medical product with permanently negatively charged surface |
| CN115003233A (zh) * | 2019-12-20 | 2022-09-02 | 皇家飞利浦有限公司 | 慢性凝块的电解重塑 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1504101A (en) | 1978-03-15 |
| JPS521987A (en) | 1977-01-08 |
| CA1054893A (en) | 1979-05-22 |
| FR2311559B1 (enrdf_load_stackoverflow) | 1982-08-06 |
| FR2311559A1 (fr) | 1976-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2357354C2 (de) | Katheter mit äußerst geringer Neigung zur Thrombenbildung | |
| EP1314405B1 (de) | Implantat mit proliferationshemmender Substanz | |
| DE69918714T2 (de) | Herstellung von kollagenmaterial mit in vivo kontrollierter bioabbaubarkeit | |
| EP0302186B1 (de) | Medizinisches Gerät und Verfahren zu seiner Herstellung | |
| DE2129004B2 (de) | Kunstliches Blutgefäß | |
| DE69007631T2 (de) | Anti-infektiöse und gleitfähige medizinische Gegenstände und Verfahren zu deren Herstellung. | |
| DE2852319C2 (enrdf_load_stackoverflow) | ||
| DE2508570A1 (de) | Prothese | |
| DE2945138C2 (enrdf_load_stackoverflow) | ||
| DE19851334C2 (de) | Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung | |
| DE69933572T2 (de) | Verwendung von citrat in einer kathetersperrlösung | |
| DE102018110591B4 (de) | Medizinische Vorrichtung mit Fibrinbeschichtung, System und Set mit einer derartigen Vorrichtung sowie Herstellverfahren | |
| EP1562565A2 (de) | Verwendung eines oder mehrerer der elemente aus der gruppe yttrium, neodym und zirconium | |
| DE2515600A1 (de) | Reinigungsloesung fuer wunden | |
| DE2622394A1 (de) | Implantationskatheter | |
| AT395677B (de) | Verfahren zur herstellung hochstabiler weichgelatinekapseln fuer therapeutische zwecke | |
| EP1915183B1 (de) | Verwendung von nichtionischen estern in einer beschichtung für mit blut in kontakt kommende oberflächen | |
| DE3871677T2 (de) | Verfahren zu herstellung eines kuenstlichen blutgefaesses. | |
| DE3017711A1 (de) | Mittel zur verhinderung oder verringerung von adhaesionsbildungen oder zur beseitigung oder aufloesung vorhandener adhaesionen bei koerpergeweben | |
| DE102012002209A1 (de) | Biodegradierbares Vlies für medizinische Zwecke | |
| DE69029786T2 (de) | Antithrombogene und/oder antimikrobielle Zusammensetzungen | |
| DE2531588C2 (de) | Transplantate aus Nabelschnurgefäßen und ihre Herstellung | |
| DE102004011293A1 (de) | Antimikrobielles medizintechnisches Produkt | |
| WO2004009148A1 (de) | Beschichtungszusammensetzung für eine implantierbare medizinische vorrichtung und verfahren zur beschichtung einer solchen vorrichtung | |
| DE10231811A1 (de) | Füllfertig vorbefeuchtete, antimikrobiell ausgerüstete Nahrungsmittelhülle auf Polymerbasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: SAWYER, PHILIP NICHOLAS, DR., BROOKLYN, N.Y., US |
|
| 8128 | New person/name/address of the agent |
Representative=s name: WEICKMANN, H., DIPL.-ING. FINCKE, K., DIPL.-PHYS. |
|
| 8131 | Rejection |